{"id":"W2163563579","doi":"10.1016/s1470-2045(14)70051-8","title":"Vemurafenib in patients with BRAFV600 mutated metastatic melanoma: an open-label, multicentre, safety study","year":2014,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":292,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Vemurafenib; Rash; Adverse effect; Internal medicine; Nausea; Clinical endpoint; Population; Dacarbazine; Expanded access; Interim analysis; Dermatology; Surgery; Oncology; Gastroenterology; Clinical trial; Metastatic melanoma; Chemotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008565424,0.0002027964,0.0004658466,0.00003626823,0.0001116208,0.0000320516,0.0007621847,0.00008911734,0.00003136113],"category_scores_gemma":[0.00008864375,0.0001288284,0.00001439172,0.0001283641,0.00009072247,0.00001159497,0.000287441,0.0001742917,0.00002654937],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003805126,"about_ca_system_score_gemma":0.00009390497,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001597276,"about_ca_topic_score_gemma":0.002767909,"domain_scores_codex":[0.9977329,0.0009934418,0.000290902,0.0004320044,0.0001335063,0.0004171795],"domain_scores_gemma":[0.9989026,0.00007119676,0.0001527292,0.0007030849,0.00007953819,0.00009084617],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03173159,0.02464643,0.8312964,0.00009524908,0.0009929746,0.0001539584,0.005303311,0.0005121012,0.03734244,0.001739132,0.003532278,0.06265417],"study_design_scores_gemma":[0.0794867,0.03651858,0.7938864,0.00002380918,0.0002105868,0.00002348256,0.0009328782,0.0006405738,0.002768065,0.0001915384,0.08456129,0.0007560689],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949029,0.00003055717,0.00009614218,0.0002278753,0.000159994,0.001155267,0.00002781649,0.00001745484,0.003381978],"genre_scores_gemma":[0.997593,0.000009733186,0.0008644376,0.0008209051,0.0001577181,0.00008422242,0.0002605195,0.00002835804,0.0001811265],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08102901,"threshold_uncertainty_score":0.5253468,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03517410555670822,"score_gpt":0.3139019102081614,"score_spread":0.2787278046514532,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}